91����

Fehmi Yasin, inspired by a high school teacher, now researches quantum materials at 91����, aiming to transform information technology with advanced imaging techniques.

Troy Carter, director of the Fusion Energy Division at 91����, leads efforts to make fusion energy a reality, overseeing key projects like MPEX and fostering public-private collaborations in fusion research. 

Scientists at ORNL have developed a method that can track chemical changes in molten salt in real time — helping to pave the way for the deployment of molten salt reactors for energy production.

US ITER has completed delivery of all components for the support structure of the central solenoid, the 60-foot-tall superconducting magnet that is the “heart” of the ITER fusion machine. 

During his first visit to 91����, Energy Secretary Chris Wright compared the urgency of the Lab’s World War II beginnings to today’s global race to lead in artificial intelligence, calling for a “Manhattan Project 2.”

Working at nanoscale dimensions, billionths of a meter in size, a team of scientists led by ORNL revealed a new way to measure high-speed fluctuations in magnetic materials. Knowledge obtained by these new measurements could be used to advance technologies ranging from traditional computing to the emerging field of quantum computing. 

P&G is using simulations on the ORNL Summit supercomputer to study how surfactants in cleaners cause eye irritation. By modeling the corneal epithelium, P&G aims to develop safer, concentrated cleaning products that meet performance and safety standards while supporting sustainability goals.

Scientists designing the world’s first controlled nuclear fusion power plant, ITER, needed to solve the problem of runaway electrons, negatively charged particles in the soup of matter in the plasma within the tokamak, the magnetic bottle intended to contain the massive energy produced. Simulations performed on Summit, the 200-petaflop supercomputer at ORNL, could offer the first step toward a solution.

Ryan Culler is the program manager at 91����, where he oversees the production of actinium-225, a promising treatment for cancer. Driven by a personal connection to cancer through his late brother, Culler is dedicated to advancing medical isotopes to help improve cancer care. 

The US focuses on nuclear nonproliferation, and ORNL plays a key role in this mission. The lab conducts advanced research in uranium science, materials analysis and nuclear forensics to detect illicit nuclear activities. Using cutting-edge tools and operational systems, ORNL supports global efforts to reduce nuclear threats by uncovering the history of nuclear materials and providing solutions for uranium removal.